中国药品生产流通的体制现状及存在的主要问题

发布时间：2018-10-25 13:27

【摘要】：改革开放以来,我国药品生产流通从计划控制转向市场化经营,形成了比较完善的管理制度和多元化的生产经营主体。但由于实行以药养医制度,公立医院垄断药品购销,加之价格管理、市场监管、招标采购和医保支付制度尚不完善,导致药品生产行业出现产业集中度低、新药研发创新能力弱、生产管理现代化水平低等问题,流通行业出现市场集中度低、流通环节加价过高、流通秩序混乱、发展布局不合理、现代化水平低等问题。促进药品生产流通行业健康发展,必须加快推进医药分开和公立医院改革,充分发挥价格引导和医保机构的监督约束作用,加快完善药品集中采购制度,并不断提高药品生产流通的市场集中度和现代化水平。
[Abstract]:Since the reform and opening up, China's drug production and circulation has changed from planned control to market-oriented management, forming a relatively perfect management system and diversified production and operation main body. However, due to the implementation of the system of raising medicine with drugs, the monopoly of the purchase and sale of drugs in public hospitals, the imperfect system of price management, market supervision, bidding and procurement, and the payment system for medical insurance, there is a low degree of industrial concentration in the pharmaceutical production industry. The new drug research and development innovation ability is weak, the production management modernization level is low, the circulation profession appears the market concentration degree is low, the circulation link price increase is too high, the circulation order is chaotic, the development layout is unreasonable, the modernization level is low, and so on. To promote the healthy development of the pharmaceutical production and circulation industry, it is necessary to speed up the separation of medicine and the reform of public hospitals, give full play to the role of price guidance and supervision and restraint of medical insurance institutions, and speed up the improvement of the centralized drug procurement system. And constantly improve the drug production and circulation of the market concentration and modernization level.
【分类号】：F426.72;F724

【参考文献】